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Human essential hypertension, as well  as experimental  renal hypertension, 
has been considered by many investigators to be the result of the release into 
the circulation of a pressor substance elaborated by the kidneys. The confirma- 
tion of this theory would appear to require the isolation and identification of a 
pressor material from the blood of human beings with hypertension which is of 
renal origin and is present in sufficient quantities to be the cause of the elevation 
of the blood pressure.  Prominent among the pressor substances suspected of 
being the  chemical mediator of hypertension is the powerful vasoconstrictor 
substance, hypertensin, which is produced by the action of the renal enzyme 
renin upon its plasma substrate  ~-2-globulin.  Hypertensin  has  been  isolated 
from the  circulating blood of dogs with  benign and  malignant experimental 
renal hypertension by use  of an artificial kidney. The methods employed in 
these  experiments  were  not adequate  to prove or disprove  that  hypertensin 
was  the  effective agent  in  elevating  the  blood pressure  of  the  hypertensive 
animals (1, 2). A direct method for the isolation and assay of hypertensin from 
blood was therefore developed (3).  This study is concerned with the applica- 
tion of this method to the isolation and assay of hypertensin in the blood of 
human beings with normal blood pressures and those with benign and malig- 
nant hypertension. 
Methods 
Collection of Blood Saraples.--The patient's right femoral area was shaved. 30 to 60 min- 
utes prior to the procedure, 0.1 to 0.2 gin. of short-acting barbiturate was administered by 
mouth unless contraindicated. The area of skin previously shaved was prepared in the usual 
manner with merthiolate and draped with sterile towels. The skin and subcutaneous tissues 
down to and around the femoral artery were infiltrated with 1 per cent procaine. A Coumand 
18-gauge arterial puncture needle was introduced through the skin and subcutaneous tissues 
2 to 3 cm. below the right inguinal ligament and advanced in a cephalodorsal direction into 
the femoral artery. The styler was withdrawn and the needle quickly connected to a short 
polyethylene catheter with an internal diameter of 0.047 inch, which had  been inserted 
through a rubber stopper into an Erlenmeyer flask containing 1 liter of 95 per cent ethanol. 
A partial vacuum was maintained in the flask so that the blood ran rapidly from the artery 
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into the alcohol,  minimizing any enzymatic action of renin on its substrate  a-2-globulin  to 
form hypertcnsin as well as preventing the destruction  of  preexisting  hypertensin by hyper- 
tensinase  present  in  the blood.  The Erlenmeyer flask  containing  the  ethanol was first  weighed 
on a torsion  balance and then 265 gin.  of  arterial  blood representing  250 ml. was collected  for 
each sample. It took on the average about 4 to 6 minutes to collect  each sample. At the end 
of the collection,  the needle was quickly  withdrawn from the artery and firm  pressure was 
maintained  over  the  point of  puncture  for  5 to 10  minutes. No hematomata or  other  untoward 
effects  were noted in any case.  During the collection  of the blood, the Erlenmeyer flask  was 
alternately  agitated  and weighed so that there  was an immediate mixture of  the alcohol  and 
blood, thereby rapidly inactivating  and precipitating  the enzymes along with most of the 
protein. 
After thorough mixing, the blood and alcohol  mixture was filtered  on a Buchncr funnel. 
The precipitated  proteins  were washed on the funnel with 1 liter  of 80 per cent alcohol. 
The alcoholic  filtrate  and  the  washings  were  combined  and  stored  in  deepfreeze  until  chemically 
processed. 
Purification  of  Extra~ts.--The  alcoholic  filtrates  were submitted to a chemical procedure 
which has recently  been described in detail  (3).  Briefly  the alcoholic  solution  was acidified, 
concentrated by vacuum evaporation,  the residual  denatured  protein  removed by centrifuga- 
tion,  and the  concentrate extracted  with  ether  to  remove lipids.  The solution  was then  further 
evaporated to the point of saturation  with sodium chloride.  The hypertcnsin was extracted 
into  butanol from the acidified  saturated salt  solution  and then was adsorbed from it onto a 
column of alumina by passage of the butanol extract  through it.  Impurities  were eliminated 
by washing the column with 85 per cent alcohol.  The active  material  in  greatly  purified  form 
was then removed from the column by elufion  with 50 per cent alcohol.  This alcoholic  solu- 
tion  was then concentrated by vacuum evaporation to a final  volume of I ml. The pH was 
adjusted to neutrality  and the extract  stored  in the frozen  state  until  assayed. 
The blood  samples  were  processed  in  groups  of  4,  all  operations  being conducted in  parallel. 
One control  sample was included in each group and consisted  of a sample of dog or human 
blood to which a known amount of hypertensin had been added. This procedure permitted 
close  control  of the percentage of  hypertensin recovered in all  experiments. 
Previously rcported experiments showed that the method recovered between 40 per cent 
and 65 per cent of  hypertcnsin added to individual  blood samples. The average recovery was 
50  per  cent.  The same percentage of  recovery was obtained in  control  samples throughout  the 
present set of experiments. No diffcrence  in the recovery of hypertensin was noted between 
human and dog blood. 
Extracts of  blood  prepared in  this  manner were found to  contain 0.22 m.eq. of  Na, 0.0011 
m.cq. of  K, 2.71  rag.  of  total  N2,  and 28.5  rag.  of  total  solids  as  computed for a single  prel~ara- 
tion  from 250 ml. of blood. 
InacHvation Experiments.--The effect  of trypsin on the pressor activity of extracts was 
determined in all cases  in which sufficient active material was available after assay. The 
details of the procedure used have been previously described (3). 
Assay Methods.--The pressor effect of the preparation was assayed by intravenous injec- 
tion into rats and compared to that produced by an injection of a  standardized hypertensin 
solution. All assays are  in terms  of Goldblatt units. A  detailed description of  the assay 
methods has been previously published (3). 
E  XPE]~  ~  NTAL 
Arterial  blood  for  hypertensin  assay  was  obtained  from  three  groups  of 
patients:  (a)  normotensive controls;  (b)  hypertensive  cardiovascular  disease, KAHN,  SKEGGS,  SHUMWAY,  AND  WISF.NBAUGH  525 
benign phase; and  (c)  hypertensive cardiovascular disease,  malignant phase. 
Normotensive Controls.--These  patients were in the hospital for conditions 
unrelated  to  cardiovascular  disease  and  had  no  history  of hypertension  or 
renal disease. Their average blood pressures were well below 150 ram. of mercury 
systolic and  100  ram.  of mercury diastolic.  Their eyegrounds were  normal, 
the heart was normal in size by physical examination and x-ray, and there was 
TABLE I 
Assay ~  Hyp~tmsin  ~Blo~  ~  Pat~n~wi~ NormalB~odPr~sur¢ 
Patient 
V. D. D. 
L. G. B. 
J.G. 
D. A. A. 
M. F. B. 
M. F. H. 
R. R. R. 
J.A. 
S. F. S. 
O. D. W. 
R. C. P. 
W. L. F. 
j. G.B. 
J. W. H. 
W. T. W. 
T. G. H. 
G.H. 
H. W. E. 
P. J. L. 
P. C. F. 
J.J. 
S.W. 
C. C. G. 
F.B. 
26 
64 
23 
20 
24 
32 
26 
25 
28 
26 
26 
37 
32 
53 
45 
33 
30 
27 
41 
41 
36 
31 
29 
28 
Sex 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
Systolic blood 
pressure 
ram. of Hg 
120 
120 
118 
130 
124 
114 
114 
130 
120 
130 
130 
120 
119 
115 
119 
116 
125 
135 
118 
125 
126 
120 
124 
108 
Diastolic blood 
pressure 
ram. of rig 
65 
80 
74 
8O 
68 
60 
90 
9O 
6O 
74 
8O 
70 
65 
80 
85 
80 
80 
84 
80 
75 
79 
82 
70 
78 
Hy•ertensln  ound 
units #er liter 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.01 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.03 
0.03 
0.05 
0.05 
no  evidence  of  arteriosclerosis.  Renal  function  was  normal  as  indicated  by 
routine urinalyses. 
Asmy of the extracts of the blood rumples from this group, which consisted 
of 24 patients, yielded values which ranged from 0.00 to 0.05 units per liter of 
blood. The average value obtained was  0.014  unit  per  liter.  The  results  are 
shown in Table I. 
Hypertensive  Cardiovascular  Disease,  Benign  Phase.--These  patients,  for 
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cardiovascular disease. However,  in a  few cases, hypertension was discovered 
in patients who had been admitted for some other reason. The average blood 
pressures  of  these  individuals were above 145  mm.  of  mercury systolic and 
100  ram.  of mercury diastolic. Their cardiac status varied from  that of indi- 
viduals  with  no  evidence  of abnormality  by  history,  physical examination, 
EKG,  and  x-ray  to  that  of  patients  who  had  been  admitted  with  varying 
degrees of congestive heart failure and cardiac enlargement. Ophthalmoscopic 
examinations revealed no more than grade II hypertensive retinopathy.  Most 
TABLE II 
Assay of Hypertensin in the Blood of Patients with Benign Essential Hypertension 
Patient 
A. J. L. 
A.N. 
A.P. 
E. E. A. 
A. J. L. 
F. P. T. 
C.A. 
F. A. B. 
R. L. W. 
H.P. 
A. F. B. 
M.S. 
H. E. G. 
L. A. G. 
F.S. 
A. F. B. 
C. D. K. 
C.M. 
Age 
36 
56 
62 
59 
36 
55 
57 
62 
43 
55 
44 
51 
59 
63 
37 
44 
57 
54 
Sex 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
Systolic  blood 
pressurc 
ram. ol II~ 
204 
173 
202 
187 
204 
210 
164 
165 
201 
198 
146 
212 
156 
195 
170 
146 
174 
206 
Diastolic blood 
pressure 
ram. of Hg 
135 
111 
103 
112 
135 
142 
105 
116 
134 
130 
100 
129 
120 
115 
106 
100 
106 
125 
Hypertensin 
found 
units per liter 
0.00 
0.00 
0.00 
0.00 
0.02 
0.02 
0.02 
0.02 
0.02 
0.03 
0.03 
0.03 
0.04 
0.04 
0.05 
0.05 
0.06 
0.06 
of these patients showed only grade I  changes.  Renal function was normal in 
most instances as indicated by routine urinalyses and the usual clinical renal 
function studies. In a  few of these patients, there was minimal impairment of 
renal  function  as  indicated  by  slight  albuminuria,  slight  limitation  of  the 
concentrating  ability of  the  kidneys as  well as minimal  depressions  of urea 
clearance and P.S.P. excretion. 
The concentration of hypertensin found in the blood of this group, consisting 
of 18 patients, ranged between 0.00 and 0.06 units per liter. The average con- 
centration was 0.028 unit per liter. The results are shown in Table II. 
Hypertensive Cardiovascular Disease, Malignant Phase.--These patients had 
been admitted to the hospital because of the severity or rapid progression of KAHN,  SKEGGS, SHUM'WAY, AND  WISF-NBAUGtt  527 
their hypertensive cardiovascular disease. Their mean blood pressures ranged 
well  over  150  ram.  of mercury systolic and  100  mm.  of mercury diastolic. 
Ophthalmoscopic examination  revealed grade  III  to  grade  IV hypertensive 
retinopathy. These patients all showed varying degrees of cardiac enlargement, 
and many of them had some degree of congestive failure at some time during 
their hospital course. Renal function was markedly impaired in these patients 
as indicated by albuminuria, hematuria, oliguria, a  low fixed specific gravity 
of the urine, and increasing nitrogen retention. There was no history of primary 
renal disease in any case. 
Most of the patients in this group have since died, and of those who were 
autopsied,  everyone showed varying degrees of necrotizing arteriolitis,  con- 
TABLE III 
Assay of HyperWnsin in the Blood of Patients wilh Malignant  Essential Hypertenrion 
Patient  Age  Sex  Systolic blood  Diastolic  blood  Hypertensln 
pressure  pressure  found 
C.S. 
L. A. S. 
F. J. W. 
R. J. H. 
A. H. A. 
J. A. G. 
G.T. 
M.J. 
L.G. 
L.T. 
32 
33 
32 
51 
62 
38 
54 
48 
47 
42 
M 
M 
M 
M 
M 
M 
M 
F 
F 
F 
ram. 41tg 
227 
202 
205 
225 
220 
206 
203 
300 
289 
247 
ram. oI1t~ 
150 
146 
149 
133 
120 
134 
148 
160 
159 
149 
units per liter 
0.08 
0.10 
0.11 
0.11 
0.31 
0.24 
0.24 
0.24 
0.40 
0.40 
0.43 
sistent with the clinical diagnosis of the malignant phase of essential hyper- 
tension. The one patient with benign hypertension, who died and was autop- 
sled,  had  no evidence of necrotizing arteriolitis.  The cause of death  in  this 
case was myocardial infarction  with  mural  thrombosis and multiple emboli. 
Concentrations of hypertensin ranging between 0.08 and 0.43 units per liter 
were found in this group of 10 patients. The average value was 0.27  unit per 
liter. The results are tabulated in Table III. 
DISCUSSION 
The pressor material obtained from arterial blood in this study was identified 
as hypertensin by the following means. The active pressor material from 10 
patients  with  malignant  hypertension,  6  with  benign  hypertension,  and  2 
normotensives was tested for susceptibility to  destruction  by trypsin. In  all 
cases tested, the activity was completely destroyed, thus eliminating all other 528  ItYPERTENSIN  IN  NORMOT]~N$IVE  AND  HYPERTENSIVE  PATIENTS 
known pressor  materials with the exception  of ACTH and pitressin.  These 
two possibilities were excluded by comparison  of the contour of  the pressor 
response  obtained, as well as by failure  to recover  these substances  by the 
method used when reasonable amounts of them were added to blood samples (3). 
The average concentration of hypertensin found in the blood of patients with 
malignant hypertension was  approximately 20  times  the  average  concen- 
tration found in the blood of the patients serving as controls. All values ob- 
tained  in  the  malignantly hypertensive group  are  greater  than  the  largest 
normal value found. This is, therefore,  a  significant difference and hence the 
inference  seems justified  that hypertensin contributes in some degree  to the 
maintenance of elevated blood pressure in patients with malignant hyperten- 
sion. This finding is in keeping with the concept of the renal origin of hyper- 
tension set forth by Goldblatt and his coworkers (4). 
The average  concentration of hypertensin found in the blood  of patients 
with benign hypertension was twice that found in the "normal"  group.  The 
degree  of overlapping  is marked but the difference is statistically significant 
when subjected to the g-test (P  =  0.03 at the 5 per cent level). It should be 
noted, however, that the concentration of hypertensin found in both the benign 
and normal groups is very low. Therefore, it would be unwise to draw specific 
conclusions as  to  the  participation  of  the  renin-hypertensin mechanism  in 
causing the elevation of blood pressure in benign essential hypertension.  It is 
possible  that  during  some  portions  of each  day, the  patients may secrete 
moderate amounts of this material which  could not be detected by a  single 
sampling; for the method as thus far developed does not lend itself to multiple 
determinations at intervals throughout the day. It would also seem possible 
that after prolonged and continuous constriction  of the arterioles,  due to hy- 
pertensin, that only minimal amounts of it would be needed  to maintain an 
elevated blood pressure. 
Experiments designed to determine whether prolonged  infusions of hyper- 
tensin over weeks and months will maintain a sustained rise in blood pressure, 
even though declining amounts of hypertensin are injected,  are planned for 
the future. This experiment  must be done to clarify the point. It is certainly 
important to ascertain whether the elevation  of blood  pressure  occurring  in 
benign essential hypertension is of renal origin, and is due to the renin-hyper- 
tensin mechanism. 
SD'M~tAI~Y 
Hypertensin has been  assayed in the blood  of patients with normal blood 
pressure  and  in  those with essential  hypertension in  both  the  benign  and 
malignant phases. 
250  ml. samples  of arterial blood  were obtained, chemically purified,  and KAttN,  SKEGGS~ SttlTM~rAy~ AND  WISENBAUGH  529 
concentrated to a  volume of 1 ml. These extracts were then assayed in anes- 
thetized rats. 
The concentrations of hypertensin in the blood of patients with the malignant 
phase of essential hypertension were found to be greatly increased. The con- 
centrations of hypertensin found in patients with benign hypertension had a 
moderate degree of overlapping with those found in the normotensive group, 
but the mean concentration of hypertensin in the former group was twice that 
of the controls. Although these results are statistically significant, the amounts 
of hypertensin recovered in the benign group are so small that no conclusions 
can  be  drawn  as  to  its  effectiveness in  producing vasoconstriction in  these 
patients. 
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